Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00325949 · ClinicalTrials.gov registry record · Phase 3
A Study of Pain Relief in Low Back Pain
A Phase 3 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 3
- Development phase
- 770
- Enrollment target
NCT00325949: Completed Phase 3 study, sponsored by Abbott.
NCT00325949 is a Phase 3 study that has completed, run by Abbott. The registered enrollment target is 770 participants, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00325949, a Phase 3 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 770 participants
- Enrollment target
Study Summary
This is a study of the safety and pain-relieving ability of extended release hydrocodone and acetaminophen tablets in patients with moderate to severe low back pain
Primary Outcome
Pain intensity difference assessed by the Chronic Low Back Pain Intensity Score (100mm Visual Analog Scale)
Interventions
- DRUG placebo
- DRUG Extended release hydrocodone and acetaminophen (Vicodin CR)
- DRUG hydrocodone/acetaminophen extended release (Vicodin CR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 770 participants |
| Start Date | 2006-05 |
| Est. Completion | 2007-06 |
| Phase | Phase 3 |
What the finished NCT00325949 record still lists
NCT00325949 is an interventional study that assigns participants to a tested intervention. The registered 770 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00325949 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00325949 about?
NCT00325949 is a clinical study titled "A Study of Pain Relief in Low Back Pain". This is a study of the safety and pain-relieving ability of extended release hydrocodone and acetaminophen tablets in patients with moderate to severe low back pain
What is the current status of trial NCT00325949?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 770 participants. The study started on 2006-05. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00325949?
The interventions under investigation include: placebo (DRUG), Extended release hydrocodone and acetaminophen (Vicodin CR) (DRUG), hydrocodone/acetaminophen extended release (Vicodin CR) (DRUG).
Who is sponsoring clinical trial NCT00325949?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00325949's enrollment target sits among peer trials
770 440th of 2000 higher than 1,557 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05977348 · 770 participants · NA
Increasing Food Literacy in Preschoolers to Reduce Obesity Risk
- NCT06376994 · 770 participants · Phase 3
Multi-Center Clean Air Randomized Controlled Trial in COPD
- NCT06824467 · 770 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- NCT06907173 · 770 participants · Phase 3
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia